Nanocarriers as an emerging platform for cancer therapy
2007 · Nature Nanotechnology · 8,448 citations
https://doi.org/10.1038/nnano.2007.387
D
Dan Peer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
217
Papers
23.9K
Citations
63
h-index
136
i10-index
Dan Peer is an academic researcher from Tel Aviv University. The author has contributed to research in topics: RNA Interference and Gene Delivery & Advanced biosensing and bioanalysis techniques & Nanoparticle-Based Drug Delivery. The author has an h-index of 63, co-authored 185 publications.
ORCID: 0000-0001-8238-0673Papers by this author
worksProgress and challenges towards targeted delivery of cancer therapeutics
2018 · Nature Communications · 2,092 citations
https://doi.org/10.1038/s41467-018-03705-y
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
2020 · Science Advances · 554 citations
https://doi.org/10.1126/sciadv.abc9450
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
2018 · Nature Communications · 288 citations
https://doi.org/10.1038/s41467-018-06936-1
On the issue of transparency and reproducibility in nanomedicine
2019 · Nature Nanotechnology · 219 citations
https://doi.org/10.1038/s41565-019-0496-9
Nanotechnology-based strategies against SARS-CoV-2 variants
2022 · Nature Nanotechnology · 138 citations
https://doi.org/10.1038/s41565-022-01174-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat